Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080384585> ?p ?o ?g. }
- W2080384585 endingPage "155" @default.
- W2080384585 startingPage "151" @default.
- W2080384585 abstract "We tested the efficacy and safety of glutamine (0.6 gm/kg/day) and creatine (5 gm/day) in 50 ambulant boys with Duchenne muscular dystrophy in a 6-month, double-blind, placebo-controlled clinical trial. Drug efficacy was tested by measuring muscle strength manually (34 muscle groups) and quantitatively (10 muscle groups). Timed functional tests, functional parameters, and pulmonary function tests were secondary outcome measures. Although there was no statistically significant effect of either therapy based on manual and quantitative measurements of muscle strength, a disease-modifying effect of creatine in older Duchenne muscular dystrophy and creatine and glutamine in younger Duchenne muscular dystrophy cannot be excluded. Creatine and glutamine were well tolerated." @default.
- W2080384585 created "2016-06-24" @default.
- W2080384585 creator A5001106334 @default.
- W2080384585 creator A5006304334 @default.
- W2080384585 creator A5010078401 @default.
- W2080384585 creator A5019729016 @default.
- W2080384585 creator A5020091694 @default.
- W2080384585 creator A5024521380 @default.
- W2080384585 creator A5025250099 @default.
- W2080384585 creator A5025781296 @default.
- W2080384585 creator A5030836934 @default.
- W2080384585 creator A5038576080 @default.
- W2080384585 creator A5039717492 @default.
- W2080384585 creator A5040374766 @default.
- W2080384585 creator A5040942918 @default.
- W2080384585 creator A5043897574 @default.
- W2080384585 creator A5047421271 @default.
- W2080384585 creator A5048460928 @default.
- W2080384585 creator A5050972478 @default.
- W2080384585 creator A5051937395 @default.
- W2080384585 creator A5056786004 @default.
- W2080384585 creator A5060499245 @default.
- W2080384585 creator A5064997342 @default.
- W2080384585 creator A5075751295 @default.
- W2080384585 creator A5088649964 @default.
- W2080384585 creator A5088672649 @default.
- W2080384585 creator A5089036955 @default.
- W2080384585 date "2005-06-27" @default.
- W2080384585 modified "2023-10-03" @default.
- W2080384585 title "CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy" @default.
- W2080384585 cites W1987369104 @default.
- W2080384585 cites W2005402291 @default.
- W2080384585 cites W2046966094 @default.
- W2080384585 cites W2053920975 @default.
- W2080384585 cites W2076307303 @default.
- W2080384585 cites W2127138297 @default.
- W2080384585 cites W2141358764 @default.
- W2080384585 cites W2327656791 @default.
- W2080384585 doi "https://doi.org/10.1002/ana.20523" @default.
- W2080384585 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15984021" @default.
- W2080384585 hasPublicationYear "2005" @default.
- W2080384585 type Work @default.
- W2080384585 sameAs 2080384585 @default.
- W2080384585 citedByCount "99" @default.
- W2080384585 countsByYear W20803845852012 @default.
- W2080384585 countsByYear W20803845852013 @default.
- W2080384585 countsByYear W20803845852014 @default.
- W2080384585 countsByYear W20803845852015 @default.
- W2080384585 countsByYear W20803845852016 @default.
- W2080384585 countsByYear W20803845852017 @default.
- W2080384585 countsByYear W20803845852018 @default.
- W2080384585 countsByYear W20803845852019 @default.
- W2080384585 countsByYear W20803845852020 @default.
- W2080384585 countsByYear W20803845852021 @default.
- W2080384585 countsByYear W20803845852022 @default.
- W2080384585 countsByYear W20803845852023 @default.
- W2080384585 crossrefType "journal-article" @default.
- W2080384585 hasAuthorship W2080384585A5001106334 @default.
- W2080384585 hasAuthorship W2080384585A5006304334 @default.
- W2080384585 hasAuthorship W2080384585A5010078401 @default.
- W2080384585 hasAuthorship W2080384585A5019729016 @default.
- W2080384585 hasAuthorship W2080384585A5020091694 @default.
- W2080384585 hasAuthorship W2080384585A5024521380 @default.
- W2080384585 hasAuthorship W2080384585A5025250099 @default.
- W2080384585 hasAuthorship W2080384585A5025781296 @default.
- W2080384585 hasAuthorship W2080384585A5030836934 @default.
- W2080384585 hasAuthorship W2080384585A5038576080 @default.
- W2080384585 hasAuthorship W2080384585A5039717492 @default.
- W2080384585 hasAuthorship W2080384585A5040374766 @default.
- W2080384585 hasAuthorship W2080384585A5040942918 @default.
- W2080384585 hasAuthorship W2080384585A5043897574 @default.
- W2080384585 hasAuthorship W2080384585A5047421271 @default.
- W2080384585 hasAuthorship W2080384585A5048460928 @default.
- W2080384585 hasAuthorship W2080384585A5050972478 @default.
- W2080384585 hasAuthorship W2080384585A5051937395 @default.
- W2080384585 hasAuthorship W2080384585A5056786004 @default.
- W2080384585 hasAuthorship W2080384585A5060499245 @default.
- W2080384585 hasAuthorship W2080384585A5064997342 @default.
- W2080384585 hasAuthorship W2080384585A5075751295 @default.
- W2080384585 hasAuthorship W2080384585A5088649964 @default.
- W2080384585 hasAuthorship W2080384585A5088672649 @default.
- W2080384585 hasAuthorship W2080384585A5089036955 @default.
- W2080384585 hasConcept C126322002 @default.
- W2080384585 hasConcept C142724271 @default.
- W2080384585 hasConcept C1862650 @default.
- W2080384585 hasConcept C204787440 @default.
- W2080384585 hasConcept C27081682 @default.
- W2080384585 hasConcept C2776356578 @default.
- W2080384585 hasConcept C2778943923 @default.
- W2080384585 hasConcept C2779030066 @default.
- W2080384585 hasConcept C2779134260 @default.
- W2080384585 hasConcept C2779349466 @default.
- W2080384585 hasConcept C2779896295 @default.
- W2080384585 hasConcept C515207424 @default.
- W2080384585 hasConcept C535046627 @default.
- W2080384585 hasConcept C55493867 @default.
- W2080384585 hasConcept C71924100 @default.
- W2080384585 hasConcept C86803240 @default.